Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic Effects of Enfuvirtide in Healthy Volunteers
NCT00657761Phase 4Completed
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Sep 2005
- Primary completion
- Mar 2006
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of enfuvirtide in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Hospital Clínic de Barcelona. Primary endpoint: Change in fasting plasma total cholesterol at 6 weeks. Started Sep 2005; status: completed.
02
Drugs
enfuvirtide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00657761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00657761.